361194
trans-3-Bromo-N-ethylcinnamamide
technical grade, 90%
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Fórmula lineal:
BrC6H4CH=CHCONHC2H5
Número de CAS:
Peso molecular:
254.12
Número MDL:
Código UNSPSC:
12352100
ID de la sustancia en PubChem:
grado
technical grade
Análisis
90%
mp
89-91 °C (lit.)
cadena SMILES
CCNC(=O)\C=C\c1cccc(Br)c1
InChI
1S/C11H12BrNO/c1-2-13-11(14)7-6-9-4-3-5-10(12)8-9/h3-8H,2H2,1H3,(H,13,14)/b7-6+
Clave InChI
LDCXGZCEMNMWIL-VOTSOKGWSA-N
¿Está buscando productos similares? Visita Guía de comparación de productos
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
E A Lane et al.
Journal of pharmaceutical sciences, 72(11), 1352-1354 (1983-11-01)
The dose-dependent nonlinearity of the clearance of cinromide, a medium extraction ratio drug, has been established in two monkeys. Special problems encountered in evaluation of nonlinearity of such drugs were resolved by the experimental design: cinromide was infused to steady
Prediction of steady-state behavior of metabolite from dosing of parent drug.
E A Lane et al.
Journal of pharmaceutical sciences, 69(5), 610-612 (1980-05-01)
A J Wilensky et al.
Epilepsia, 24(4), 401-409 (1983-08-01)
Monotherapy with the experimental antiepileptic drug cinromide was evaluated in 11 adult outpatients with uncontrolled partial epilepsy. They were treated with phenytoin for 2 months, cinromide for 4 months, and carbamazepine for 4 months. Four patients withdrew from the study
E A Lane et al.
Journal of pharmaceutical sciences, 72(5), 493-496 (1983-05-01)
Fifty percent of a cinromide dose was metabolized to an active metabolite in the rhesus monkey. The steady-state concentration of this metabolite was 3-6 times that of the parent drug, depending on the route of administration. Cinromide is a medium-extraction
H M Corwin et al.
Epilepsia, 24(4), 427-430 (1983-08-01)
Cinromide (BW-122U) was evaluated in an open pilot study of absence seizures in three naive (previously untreated for absence seizures) patients (one male and two females, 7 to 8 years of age). In these naive patients, cinromide was found to
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico